These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10172643)

  • 41. Application of Bayesian inference to the bioassay data from long-term follow-up of two refractory PuO2 inhalation cases.
    Avtandilashvili M; Brey R; Birchall A
    Health Phys; 2013 Apr; 104(4):394-404. PubMed ID: 23439143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Local deposition distributions of inhaled radionuclides in the human tracheobronchial tree.
    Balásházy I; Farkas A; Hofmann W; Kurunczi S
    Radiat Prot Dosimetry; 2002; 99(1-4):469-70. PubMed ID: 12194355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact on 141Ce, 144Ce, 95Zr, and 90Sr beta emitter dose coefficients of photon and electron SAFs calculated with ICRP/ICRU reference adult voxel computational phantoms.
    Li WB; Zankl M; Schlattl H; Petoussi-Henss N; Eckerman KF; Bolch WE; Oeh U; Hoeschen C
    Health Phys; 2010 Oct; 99(4):503-10. PubMed ID: 20838091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maximum likelihood analysis of bioassay data from long-term follow-up of two refractory PuO2 inhalation cases.
    Avtandilashvili M; Brey R; James AC
    Health Phys; 2012 Jul; 103(1):70-9. PubMed ID: 22647919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparisons of 239Pu inhalation doses calculated with ICRP 67 and proposed systemic models.
    Li WB; Oeh U; Paretzke HG
    Radiat Prot Dosimetry; 2007; 127(1-4):148-52. PubMed ID: 17545662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic interpretation of the slow bronchial clearance phase.
    Sturm R; Hofmann W
    Radiat Prot Dosimetry; 2003; 105(1-4):101-4. PubMed ID: 14526936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radon progeny microdosimetry in human and rat bronchial airways: the effect of crossfire from the alveolar region.
    Fakir H; Hofmann W; Caswell RS
    Radiat Prot Dosimetry; 2008; 130(2):149-61. PubMed ID: 18223184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modeling intersubject variability of bronchial doses for inhaled radon progeny.
    Hofmann W; Winkler-Heil R; Hussain M
    Health Phys; 2010 Oct; 99(4):523-31. PubMed ID: 20838094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The computation of ICRP dose coefficients for intakes of radionuclides with PLEIADES: biokinetic aspects.
    Fell TP
    Radiat Prot Dosimetry; 2007; 127(1-4):220-2. PubMed ID: 17921508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doses from radiation exposure.
    Menzel HG; Harrison JD
    Ann ICRP; 2012; 41(3-4):12-23. PubMed ID: 23089000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twenty-year follow-up of a Pu/Am inhalation case.
    Wernli C; Eikenberg J
    Radiat Prot Dosimetry; 2007; 125(1-4):506-12. PubMed ID: 17298952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proposed revision of the ICRP model for inhaled mercury vapor.
    Leggett RW; Munro NB; Eckerman KF
    Health Phys; 2001 Oct; 81(4):450-5. PubMed ID: 11569640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Particle clearance in the alveolar-interstitial region of the human lungs: model validation.
    Gregoratto D; Bailey MR; Marsh JW
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):353-6. PubMed ID: 21036808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Worker inhalation dose coefficients for radionuclides not previously identified in ICRP publication 68.
    McLaughlin DA; Schwahn SO
    Radiat Prot Dosimetry; 2012 Mar; 148(4):428-30. PubMed ID: 21576177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiation doses to members of the U.S. population from ubiquitous radionuclides in the body: Part 2, methods and dose calculations.
    Watson DJ; Strom DJ
    Health Phys; 2011 Apr; 100(4):377-401. PubMed ID: 21350345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and application of a complex numerical model and software for the computation of dose conversion factors for radon progenies.
    Farkas Á; Balásházy I
    Radiat Prot Dosimetry; 2015 Apr; 164(3):278-90. PubMed ID: 25236336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review and critical analysis of available in vitro dissolution tests.
    Ansoborlo E; Hengé-Napoli MH; Chazel V; Gibert R; Guilmette RA
    Health Phys; 1999 Dec; 77(6):638-45. PubMed ID: 10568542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Internal dose for ingestion of molybdenum radionuclides based on a revised biokinetic model.
    Giussani A; Cantone MC; de Bartolo D; Roth P; Werner E
    Health Phys; 2000 Jan; 78(1):46-52. PubMed ID: 10608309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Mayak Worker Dosimetry System (MWDS-2013): A Bayesian Analysis to Quantify Pulmonary Binding of Plutonium in Lungs Using Historic Beagle Dog Data.
    Puncher M; Pellow PGD; Hodgson A; Etherington G; Birchall A
    Radiat Prot Dosimetry; 2017 Nov; 176(1-2):32-44. PubMed ID: 27555656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Biokinetic Model for Systemic Nickel.
    Melo DR; Leggett RW
    Health Phys; 2017 Jan; 112(1):18-27. PubMed ID: 27906784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.